E
BriaCell Therapeutics Corp. BCT.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Total Cash And Short-Term Investments 43.39% 148.53% -13.44% 571.88% -7.87%
Total Receivables -- 8.19% -11.45% 229.55% 4,744.74%
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- -55.11%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 34.77% 106.42% -12.85% 124.94% -33.93%

Total Current Assets 34.77% 106.42% -12.85% 124.94% -33.93%
Net Property, Plant & Equipment -7.16% -6.66% -6.24% -5.90% --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -2.02% -2.03% -1.94% -1.90% -1.87%
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -40.80% 0.00% 0.00% 0.00% --
Total Assets 27.34% 81.57% -10.09% 77.35% -5.34%

Total Accounts Payable 0.14% -34.46% 18.17% -40.95% 11.65%
Total Accrued Expenses -33.96% 361.95% -69.84% 159.88% -13.42%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -8.14% -17.21% 4.86% -33.14% 10.41%

Total Current Liabilities -8.14% -17.21% 4.86% -33.14% 10.41%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -53.74% -19.41% -47.11% 56.27% -80.70%
Total Liabilities -14.72% -17.54% -8.43% -21.69% -31.19%

Common Stock & APIC 8.21% 10.03% 4.16% 13.68% 3.70%
Retained Earnings -7.81% -6.28% -6.89% -6.79% -1.44%
Treasury Stock & Other 26.48% 40.59% 18.43% 21.60% 25.62%
Total Common Equity 44.02% 244.59% -10.88% 269.69% 60.06%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 44.02% 244.59% -10.88% 269.69% 60.06%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -15.33% -26.09% -14.08% -8.96% -12.92%
Total Equity 45.16% 270.05% -13.09% 238.29% 56.92%